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ABSTRACT  
Almost 85% of epilepsy patients which is a common neurolotical disease live in developing 
world. Mostly the disease start in childhood in more than half of the cases. Long term use of 
antiepileptic drugs may alter serum zinc level.   The purpose of the present study was to assess 
the serum zinc level in childhood epilepsy treated with long-term Anti-Epileptic Drug (AED). 
This cross-sectional study was carried out in the outdoor and indoor patient department of 
Pediatric neurology, BSMMU during the period from March 2013 to August 2013. Sample size 
was one hundred, among these fifty were case e.g. epileptic child who had received anti-epileptic 
drugs (Carbamazepine and/or Valproic acid) for more than three months and fifty were control 
e.g. newly diagnosed epileptic child, who have not yet received antiepileptic drugs.  In this study, 
among100 epileptic child, mean serum zinc level in case group was 0.36(±0.20)(µg/ml)and in 
control group was 0.52(±0.26) (µg/ml),which was statistically significant (p<0.05). The use of 
one drug or multiple drugs in the treatment of epileptic patients has made the significant low 
serum zinc level. 
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INTRODUCTION 
Epilepsy is a recurrent, unprovoked, seizure manifested by an abnormal and excessive 
synchronized discharge of a set of cerebral neurons. The result of this discaharge is that patient 
suffer convulsive movements, disturbance of sensation, and loss of consciousness or 
combination.
1
 Epilepsy is a common neurological disease and its occurrence is about 3 to 20 
people per 1000 in general population occurring more frequently in school children.
1,2,3,4
 In It is 
estimated that there are 1.52 million patients of epilepsy in Bangladesh. A survey related to the 
Dasher Kandi, Bangladesh shows that there is about 2.54 patient in every 1000 population in 
Bangladesh.
5
 it is estimated that two third of epileptic seizures starts in age of less than 5 years 
and seizures assumes the most array of form. Trace elements (e.g. Copper, Zinc and Manganese) 
are minor building components in tissues including the nervous system. For maintaining human 
health, there is required balance in trace elements
7
. In peripheral and central nervous systems, 
trace elements function is vital 
8-13
. Indispensable components for certain enzymes (such as 
glutathione peroxidases) include zinc, Selenium and Coooper which are responsible for brain 
metabolic processes
14 15
.  
If there is excess or deficiency of trace elements in some patient so it can lead to some disease
16
. 
The function of anti-elipetic drug is to change the blood trace elements like Zinc and 
metabolism. . Sözüer et al
20
measured serum Zinc (Zn) levels in 52 epileptic children who were 
treated with either Carbamazepine (CBZ) or Valproic acid (VPA) or with a combination of CBZ 
and VPA. Serum Zn levels were significantly lowers in the epileptics than in the two control 
groups which consisted of 7 untreated epileptics and 12 normal children.  
METHODOLOGY 
This cross-sectional study was carried out in the outdoor and indoor patient department of 
Paediatric neurology, BSMMU during the period from March’ 2013 to August’ 2013. Sample 
size was one hundred, among these fifty were case e.g. epileptic child who had received  anti-
epileptic drugs (Carbamazepine and/or Valproic acid) for more than three months and fifty were 
control e.g. newly diagnosed epileptic child, who have not yet received antiepileptic drugs. 
Clinically diagnosed patient of epilepsy from 1 month to 18 years of age and treated with 
Carbamazepine and/or Valproic acid ≥ 3months were included in this study. Epileptic children 
with other systemic illnesses such as diabetes, renal failure, malnutrition or any infectious 
diseases and receiving antiepileptic drug for less than three months or receiving antiepileptic 
drug other than studied drugs were excluded from this study. Sample was selected by non-
random sampling method. After proper selection of case & control cases, complete history had 
taken from accompanying attendants. Through clinical examination was done. Relevant 
investigation reports were collected and recorded. Serum zinc (Zn) were measured by atomic 
absorption spectrophotometer
17.
The name of spectrophotometer is graphite furnance atomic 
absorption spectrophotometer (GF-AAS, 6650, Shimadzu: KYOTO, JAPAN) and analysis was 
done in biochemistry laboratory of BSMMU (Bangabandhu Sheikh Mujib Medical University) 
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and ICDDR,B.( International Centre for Diarrhoeal Diseases Research, Bangladesh. After 
collecting all the data, analysis has been done by using SPSS.  
RESULT 
A total number of 100 children were enrolled for this study, out of which 50 were case and 50 
were control. Mean age of study population was 4.39(±2.34) years whereas case group was 
4.08(±2.21) years and control group was 4.70(±2.45) years. 
 
Table 1: Age group distribution of the study population  
 Study group  
Age group Case/Epileptic   Control Total 
1-2 years 16(32) 14(28) 30 
>2 to 5 years 21(42) 16(32) 37 
>5 years 13(26) 20(40) 33 
Total 50(100) 50(100) 100 
Mean ±SD 4.08(±2.21) 4.70(±2.45) 4.39(±2.34) 
Among the study population male female ratio was 1.63:1. 
Table 2: Sex distribution of the study group  
 Study group   
 Epileptic   Control Total 
Male 31 31 62 
Female 19 19 38 
Total 50 50 100 
 
 
Table 3: Family history of epilepsy of the study group  
Family H/O 
Epilepsy 
Study group   
Epileptic  
n(%)  
Control 
n(%) 
    Total P value 
Yes 17(34) 08(16) 25 0.001 
No 33(66) 42(84) 75 
Total 50(100) 50(100) 100 
 
Here, calculate the P value by using Chi-square test.   
By the study on family history of epilepsy, it was found that , in epileptic group 34% had family 
history of epilepsy and in control group 16% had family history of epilepsy and that was 
statistically significant (p<0.05). 
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Table 4: Character of seizure of the study population  
Here, calculate the P value by using Fisher's exact probability test. 
Table 5: EEG findings of the study population  
EEG findings Study group   
Epileptic  
n(%)  
Control 
n(%) 
Total P value 
Generalized 
seizures 
32(64) 27(54) 59 0.30 
Focal seizure 18(36) 23(46) 41 
Total 
50(100) 50(100) 100 
 
Here, calculate the P value by using Chi-square test.   
Study on EEG findings, it was found that generalized seizure in epileptic group were 64% were 
and in control group were 54%. Focal seizure in epileptic group were 36% and in control group 
were 46%, where (p>0.05) had not statically significant 
Table 6: Mean difference of serum zinc level of the epileptic group and control group.  
 Study group  
 Epileptic   Control P value 
Zn (µg/ml) 0.36(±0.20) 0.52(±0.26) <0.001 
      Here, calculate the P value by using unpaired ―t‖ test.   
Mean zinc level 0.36(±0.20)(µg/ml)  was in  epileptic group and 0.52(±0.26) was in control 
group where (p<0.05) that was statistically significant. 
Table 7:  Mean Zn (µg/ml) level between different anti-epileptic drugs   
 Epileptic patients    
 
Carbamazepine Valproic acid 
Carbamazepine 
andValproic acid 
P value 
Zn (µg/ml) 0.38(±0.25)   0.41(±0.23) 0.31 (± 0.13) 0.03 
     Here, calculate the P value by using ―One way ANOVA test‖. It was done by SPSS software   
version -17. In  
Character of seizure Study group   
Epileptic  
n(%)  
Control 
n(%) 
Total P  value  
Generalized tonic clonic 
39(78) 36(72) 75 
0.57 
Tonic 
06(12) 08(16) 14 
Clonic 
03(06) 04(08) 07 
Others 
02(04) 02(04) 04 
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multiple comparisons in between three drugs group (p<0.05) were significant. 
After medication with carbamazepine(CBZ),valproic acid(VPA), carbamazepine and valproic 
acid(CBZ+VPA) mean  zinc levels were 0.38(±0.25) (µg/ml), 0.41(±0.23) (µg/ml) and 0.31 (± 
0.13) (µg/ml) respectively where (p<0.05) that was statistically significant.  
DISCUSSION 
Childhood epilepsy is a worldwide problem. Trace elements (e.g. Copper, Zinc and Manganese) 
are minor building components in tissues including the nervous system. This study has been 
designed to determine the levels of zinc (Zn) in serum from patients with epilepsy in children 
who were taking anti-epileptic drugs (carbamazepine and/or valproic acid) for at least three 
months.  This was a cross-sectional study among the patients who were consulted and admitted 
at the department of Paediatric neurology, BSMMU. In this study mean age was 4.39(±2.34). In 
epileptic group mean age was 4.08(±2.21) and control group was 4.70(±2.45). As compared with 
Tekinet al.
21
 study mean age group was 4.24(±0.35) and case group was 4.69(±1.12) that result 
was approximately similar to our study. Another study by Saboktakin et al 
24
 also corroborates 
with our study. Diop et al’s25 study in Senegal  was limited to children aged between 1 to 9 
years. 
In this study sex distribution of epileptic group and control group have shown male female ratio 
was 1.63:1. A study by Nouri et al demonstrated that male-to-female ratio was 1.75:1.These 
results corroborate with our study.
26
 
 In this study, epileptic group had 34% family history of epilepsy and in control group 16% had 
family history of epilepsy and that was statistically significant (p<0.05). Saboktakin et al 
demonstrated that the family history of epilepsy were positive in 9% of epileptic patients.
24
 
In this study, 78% generalized tonic clonicseizures were in epileptic group and 70% were in 
control group. Tonic was 12% in epileptic group and 16% in control group. Clonic was 06%  
inepileptic group and 8% in control group, which was not statistically significant (p>0.05). 
Ogunlesi T et al reported that generalized tonic-clonic seizures were the commonest seizure type 
of their study (97; 76.9%). These were followed by tonic seizures (8; 6.3%), clonic seizures (6; 
4.8%) and myoclonus (3; 2.4%) 
27 
that match with this present study. 
Following the clinical diagnosis of epilepsy in an individual Osuntokon B O et al 
demonstrated that it was usually recommended an EEG, amongst other investigations, be 
carried out. The EEG provides three types of information: confirmation of an abnormal electrical 
activity; information about the type of seizure disorder and the location of the seizure 
focus.
28,29
In this present study EEG findings, generalized  seizure activity was 64%  in epileptic 
group and 54% in control group. Focal seizure was 36% in epileptic group and 46% in control 
group and those results were not statistically significant (p>0.05). However, Meindari H et al 
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conducted a EEG-based studies of epilepsy to show the frequency of seizure type. According to 
their literature, generalized seizures account for 45% of all seizure types, whereas focal seizures 
are present in 55% of cases.
30 
It is crucial to recognize that a normal EEG does not exclude 
epilepsy, as around 10% of patients with epilepsy never show epileptic form discharges. 
Secondly, an abnormal EEG demonstrating IED (interictalepileptiform discharge) does not in 
itself indicate that an individual has a seizure disorder, as IED are seen in a small percentage of 
normal subjects who never develop epilepsy and IED may also be found in patients with 
neurological disorders which are not complicated by epilepsy.
31,32. 
In this present study mean zinc level was 0.36(±0.20) (µg/ml)  in epileptic group and 0.52(±0.26) 
(µg/ml) in control group which was statistically significant (p<0.05).Studies of Saboktakin 
et.al.
24
, Barbeauset.al.
23
 and Verrotti et.al 
22
 have also corroborated with the similar results of our 
study on serum zinc  in epileptic patient under drug therapy. Saboktakin et al   demonstrated that 
the mean zinc level in children with epilepsy under drug treatment was 0.36(± 0.13) μg/ml   and 
0.43 (± 0.21) μg/ml in control group, which was lower meaningfully in epileptic patients. 
Although their control group were normal healthy subjects.Besides this, Verrotti’set al. 22 have 
demonstrated no significant difference in the levels of other elements (copper and magnesium). 
 
After medication with carbamazepine(CBZ),valproic acid(VPA), carbamazepine and valproic 
acid(CBZ+VPA) mean  zinc levels were 0.38(±0.25) (µg/ml), 0.41(±0.23) (µg/ml) and 0.31 (± 
0.13) (µg/ml) respectively where (p<0.05) that was statistically significant. Here we observed 
that combination therapy(CBZ+VPA) has more potentiality than monotherapy with CBZ or VPA 
for reducing serum zinc level of epileptic patients. 
Studies of Sherifa et.al.
33
,Sözüer DT
20
et al have also corroborated with the similar results with 
our study on serum zinc in epileptic patients.Sherifaandcolleagues demonstrated 
thatserumlevelsofzinc  inpatients with epilepsyontreatment(particularly withsodium valproate and 
carbamazepine)were low.
33
 
 
In Sözüer DT et al 
20
 demonstrated that zinc level was 0.27 ± 0.10(µg/ml) in patients treated with 
carbamazepine and 0.35 ± 0.15(µg/ml) in patients treated with sodium valproate. That result was 
showed carbamazepine was more effective than sodium valproate reducing serum zinc level of 
epileptic patients. 
 
Yanagisawa et al reported that serum zinc level 31-59 µg/dl(0.31-0.59 µg/ml) may or may not 
produce any symptom of zinc deficiency. They stated this reference range as deficiency state and 
suggested countermeasures this condition either by cause identification and removed as needed 
or dietary therapy(ingestion of zinc rich food) or zinc replacement. They mentioned that serum 
zinc level below 30 µg/dl(0.30 µg/ml)  as a definite deficiency state and produce clinical 
symptom like hair loss, diarrhea, delayed sexual maturation, impotence, hypogonadism, growth 
retardation, eye and skin lesions, weight loss, delayed healing of wounds, fever, pica, taste 
abnormalities, mental lethargy, intention tremor, depression, impaired concentration, nystagmus, 
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dysarthria, night blindness, hypogeusia, anosmia, dementia  etc. They recommended dietary 
allowance for zinc taken by mouth is: 2 milligrams oral zinc for 0 to six months of age; 3 
milligrams for seven months to three years of age; 5 milligrams for 4-8 year-olds; 8 milligrams 
for 9-13 year-olds; 11 milligrams for 14-18 year old boy; 9 milligrams for 14-18 year-old girl.
34-
35. 
As antiepileptic therapy (CBZ,VPA,CBZ and VPA) has significant potentiality to reduce serum 
zinc level in epileptic patients that may lead to morbidity due to zinc derangement therefore, 
repeated monitoring should be carried out. 
 
CONCLUSION 
The use of one drug or multiple drugs in the treatment of epileptic patients has made 
s ignif icant  differences in the levels of serum zinc. The serumlevelof 
zincinpatientundertreatment with carbamazepine and/or valproic acid was significantly lower. 
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